Pharmacological natures of caffeine-induced endothelium-dependent and -independent contraction in canine mesenteric artery

Life Sci. 1995;57(12):1155-62. doi: 10.1016/0024-3205(95)02061-m.

Abstract

The present experiments were carried out to elucidate whether pharmacological nature of caffeine (1 mM)-induced endothelium-dependent contraction (EDC) is different from that of caffeine (10 mM)-induced endothelium-independent contraction (EIC) in canine mesenteric artery. Caffeine (1 mM)-induced EDC was abolished when arterial strips were incubated in Ca(++)-free medium for 20 min, but EIC was not abolished. EGTA and EDTA (0.5 and 1 mM) attenuated the EDC, and at the concentration of 2.5 mM completely abolished the EDC. Nifedipine (10(-6) and 3 x 10(-6) M), diltiazem (10(-6) M) and verapamil (10(-6) M) did not affect the caffeine (1 mM)-induced EDC. Lemakalim (10(-8), 3 x 10(-8) and 10(-7) M) attenuated the caffeine (1 mM)-induced EDC in a concentration-dependent manner. Lemakalim (10(-7) M) nearly abolished the EDC. The inhibitory effect of lemakalim (10(-7) M) on the EDC was antagonized in the presence of glibenclamide (3 x 10(-6) M). In contrast, caffeine (10 mM)-induced EIC was resistant to lemakalim at higher concentration (3 x 10(-7) M). Forskolin (10(-7), 3 x 10(-7) and 10(-6) M) significantly attenuated both the caffeine (1 mM)-induced EDC and caffeine (10 mM)-induced EIC. The inhibitory effect of forskolin on the EDC was augmented in the presence of rolipram (10(-6) M). Nitroglycerin (10(-5) M) attenuated significantly caffeine-induced both EDC and EIC. The inhibitory effect of nitroglycerin on the EDC was augmented in the presence of zaprinast (10(-5) M). The present experiments demonstrate that caffeine-induced EDC is due to nifedipine-resistant and lemakalim-sensitive Ca++ mobilization and the EIC is due to both nifedipine- and lemakalim-resistant Ca++ mobilization in canine mesenteric artery.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylyl Cyclases / drug effects
  • Adenylyl Cyclases / metabolism
  • Animals
  • Benzopyrans / pharmacology
  • Caffeine / pharmacology*
  • Calcium / pharmacology
  • Calcium Channel Blockers / pharmacology
  • Colforsin / pharmacology
  • Cromakalim
  • Dogs
  • Edetic Acid / pharmacology
  • Egtazic Acid / pharmacology
  • Endothelium, Vascular / drug effects*
  • Endothelium, Vascular / physiology
  • Female
  • In Vitro Techniques
  • Magnesium / pharmacology
  • Male
  • Mesenteric Arteries / drug effects
  • Mesenteric Arteries / physiology
  • Muscle Contraction / drug effects*
  • Muscle Contraction / physiology
  • Muscle, Smooth, Vascular / drug effects*
  • Nifedipine / pharmacology
  • Nitroglycerin / pharmacology
  • Potassium Channels / agonists
  • Pyrroles / pharmacology
  • Vasodilator Agents / pharmacology

Substances

  • Benzopyrans
  • Calcium Channel Blockers
  • Potassium Channels
  • Pyrroles
  • Vasodilator Agents
  • Cromakalim
  • Colforsin
  • Caffeine
  • Egtazic Acid
  • Edetic Acid
  • Adenylyl Cyclases
  • Nitroglycerin
  • Magnesium
  • Nifedipine
  • Calcium